Please login to the form below

Not currently logged in
Email:
Password:

settlements

This page shows the latest settlements news and features for those working in and with pharma, biotech and healthcare.

Settlement clears path for Biogen, Samsung’s Humira biosimilar

Settlement clears path for Biogen, Samsung’s Humira biosimilar

Settlement clears path for Biogen, Samsung’ s Humira biosimilar. Agreement could see Europe access Imraldi as early as October this year. ... The Samsung Bioepis settlement reflects the strength and breadth of AbbVie's intellectual property, ”said

Latest news

More from news
Approximately 4 fully matching, plus 221 partially matching documents found.

Latest Intelligence

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Most crucial of all is the long-term funding settlement Theresa May is now promising to the NHS - likely to be timed as a birthday present when the NHS hits the

  • Creating a successful global compliance programme Creating a successful global compliance programme

    Cases show that failure to adopt an effective, global compliance programme can lead to serious repercussions, as illustrated by recent US settlements involving Orthofix, Teva Pharmaceuticals and Olympus, where domestic companies

  • Deal Watch January 2018

    Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM® Thrombin topical and PREVELEAK® Surgical Sealant to control bleeding in surgery. ... Teva/Alder Biopharmaceuticals patent settlement. We have featured Teva in

  • Risky business for pharma Risky business for pharma

    Between 1991 and 2015, 373 settlements totaling $35.7bn were reached between the US federal and state governments and pharmaceutical manufacturers.

  • Deal Watch - May 2017 Deal Watch - May 2017

    The legal case went on for another eight months until this month when Abbott and Alere announced a settlement where Abbott will pay $5bn for Alere, $0.5bn (9%) less than ... 710 (upfront 310). Alere (US). Abbott (US). Acquisition settlement. Reduction in

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics